Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Colorectal Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Lung Neoplasms 2Carcinoma, Renal Cell 2COVID-19 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Spondylitis, Ankylosing 1Renal Insufficiency, Chronic 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lupus Erythematosus, Systemic 1Localized Head and Neck Carcinoma 1Inflammatory Bowel Diseases 1Hypogonadism 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

testosterone 17 beta-cypionate 1pembrolizumab 1enfortumab vedotin 1Testosterone Propionate 1Standard of Care 1Radiation Dose Hypofractionation 1Practice Guidelines as Topic 1Mitomycin 1Methyltestosterone 1Gemcitabine 1Fluorouracil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Diseases × Practice Guidelines as Topic × 30 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡